为您找到相关结果约461个

你是不是要搜索 期刊Tislelizumab 点击跳转

Tislelizumab: First Approval

Tislelizumab for the treatment of classical Hodgkin's lymphoma

Literature analysis of cutaneous adverse reactions induced by tislelizumab

Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody

Tislelizumab-related enteritis successfully treated with adalimumab: A case report

INTERSTITIAL NEPHRITIS FOLLOWING TISLELIZUMAB: A CASE REPORT

Neoadjuvant tislelizumab plus nab-paclitaxel and carboplatin followed by adjuvant tislelizumab in patients

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial

Severe thyrotoxicosis induced by tislelizumab: a case report and literature review

Model-based population pharmacokinetic analysis of tislelizumab in patients with advanced tumors

Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers

Population pharmacokinetics of tislelizumab in patients with advanced tumors

Tislelizumab combined with anlotinib in the second-line treatment of malignant pleural mesothelioma

The Effects of Axitinib plus Tislelizumab in the Treatment of Advanced Renal Cell Carcinoma

RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular

为您找到相关结果约461个

共461条页码: 1/31页15条/页